Good Neighbor Pharmacy Cranberry Tablets Recalled for Labeling Errors
Reese Pharmaceutical is recalling Good Neighbor Pharmacy Cranberry Tablets because the label omits calcium and lists the wrong serving size.
The agency’s classification
FDA (Food): Class III
Class III is a situation in which use of or exposure to a violative product is not likely to cause adverse health consequences.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class III, which the rubric defines as typically resulting in a score of 1 or 2 because it is unlikely to cause adverse health consequences. The specific hazards are minor labeling errors regarding ingredient omission and serving size accuracy.
Plain-English summary
Reese Pharmaceutical Company is recalling Good Neighbor Pharmacy Cranberry Tablets, 450mg, 50-count cartons. The recall involves 2,880 finished goods units distributed across 19 states, including Alabama, Arizona, California, Florida, Georgia, Hawaii, Illinois, Kentucky, Massachusetts, Michigan, Minnesota, Missouri, North Carolina, Ohio, Pennsylvania, Texas, Utah, Virginia, and Washington. The specific lot number is P15J478, with an expiration date of 10/17.
The recall was initiated due to labeling errors on the finished product. The label fails to list Calcium as an ingredient, which may leave users unaware of its presence in the supplement. Additionally, the amount per serving listed on the label is incorrect; it states 900mg but should read 500mg.
Consumers who have purchased this product should check their cartons for Lot P15J478 and an expiration date of 10/17. If the product matches these details, consumers should stop using it and contact the distributor or retailer for a refund or replacement.
The recalled product
- Product
- Good Neighbor Pharmacy Cranberry Tablets, Cranberry Supplement 450mg. Urinary Health. Tablets are packed in a labeled carton, 50 tablets per carton. Distributed by Amerisource Bergen 1300 Morris Drive Chesterbrook, PA 19087.
- Manufacturer
- Reese Pharmaceutical Company
- Category
- Food — Dietary Supplement
- Affected units
- 2,880
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot P15J478
- Expiration 10/17
Distribution
Related recalls
Same manufacturer · Reese Pharmaceutical Company
See all →- ModerateReese Pharmaceutical Recalls Berry Flavor Immune Support Tablets for Labeling Error
FDA (Food) · 2017-12-06
- ModerateReese Pharmaceutical Recalls Orange Flavor Immune Support Effervescent Tablets
FDA (Food) · 2017-12-06
Same hazard · mis labeling
See all →- SevereImperio Distribution Recalls Beef Jerky Produced Without Federal Inspection
USDA FSIS · 2026-10-24
- HighJ K Patisserie Chocolate Chip Cookies Recalled for Undeclared Soy
FDA (Food) · 2026-10-14
- HighFreshPoint Recalls Cranberry Chicken Salad Wedges for Undeclared Egg Allergen
FDA (Food) · 2026-10-14
- HighJ K Patisserie & Bakery LLC Recalls Croissants for Undeclared Egg
FDA (Food) · 2026-10-14
- LowMindray ePM Series Patient Monitor Manuals Recalled for Alarm Clarification
FDA (Devices) · 2026-10-14
Similar recalls
- ModerateGood Neighbor Pharmacy Co Q10 Capsules Recalled for Mislabeling
FDA (Food) · 2019-03-13
- HighGood Neighbor Pharmacy antacid tablets contain small metallic particles
FDA (Drugs) · 2026-06-10
- ModerateReese Pharmaceutical Recalls Berry Flavor Immune Support Tablets for Labeling Error
FDA (Food) · 2017-12-06
- ModerateGood Neighbor Pharmacy Vitamin D Supplement Recalled for Mislabeling
FDA (Food) · 2019-03-13
- ModerateGood Herbs Cranberry Recalled for GMP Violations
FDA (Food) · 2014-11-05
- HighGood Neighbor Pharmacy 1000 mg antacid tablets contain metallic particles
FDA (Drugs) · 2026-06-10